Department of Neurology, Beijing Tiantan Hospital, Capital Medical University.
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University.
J Atheroscler Thromb. 2023 Jun 1;30(6):601-610. doi: 10.5551/jat.63512. Epub 2022 Aug 6.
This study aimed to investigate the relationship between symptomatic or asymptomatic intracranial/extracranial artery stenosis and high-sensitivity C-reactive protein (hs-CRP) levels in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA).
This study included 10404 patients from the Third China National Stroke Registry. Patients were divided into four or six groups according to patterns of intracranial or extracranial artery stenosis and hs-CRP levels. The outcomes were recurrence of ischemic stroke, stroke, and combined vascular events (CVE) at 1 year. The associations between different combinations of hs-CRP levels and patterns of artery stenosis and recurrent events were analyzed by multivariable Cox regression models.
Patients in Group III (hs-CRP <3+symptomatic intracranial or extracranial artery stenosis) had higher risk of recurrent ischemic stroke (adjusted hazard ratio (HR) 1.73, 95% confidence interval (CI) 1.20-2.48, p=0.003). Those in Group VI (hs-CRP ≥ 3+symptomatic intracranial or extracranial artery stenosis) had the highest risk of recurrent ischemic stroke (HR 2.04, 95% CI 1.42-2.92, p=0.0001) within 1 year compared with Group I (hs-CRP <3+no artery stenosis). Asymptomatic intracranial or extracranial artery stenosis did not increase the risk of ischemic events compared with no artery stenosis regardless of hs-CRP levels.
Symptomatic intracranial or extracranial artery stenosis was associated with increased risk of recurrent ischemic stroke, stroke, and CVE at 1 year in patients with AIS or TIA, especially in patients with elevated hs-CRP levels. Asymptomatic intracranial or extracranial artery stenosis did not increase the risk of ischemic events compared with no artery stenosis regardless of hs-CRP levels.
本研究旨在探讨急性缺血性脑卒中(AIS)或短暂性脑缺血发作(TIA)患者症状性或无症状性颅内/颅外动脉狭窄与高敏 C 反应蛋白(hs-CRP)水平之间的关系。
本研究纳入了来自中国第三次国家脑卒中登记研究的 10404 例患者。根据颅内或颅外动脉狭窄和 hs-CRP 水平的模式,患者被分为四组或六组。主要结局为 1 年内缺血性脑卒中复发、脑卒中及复合血管事件(CVE)的发生。采用多变量 Cox 回归模型分析不同 hs-CRP 水平与动脉狭窄模式组合与复发事件之间的关系。
与 Group I(hs-CRP<3+无动脉狭窄)相比,Group III(hs-CRP<3+症状性颅内或颅外动脉狭窄)患者缺血性脑卒中复发的风险更高(校正后的风险比(HR)1.73,95%置信区间(CI)1.20-2.48,p=0.003)。与 Group I 相比,Group VI(hs-CRP≥3+症状性颅内或颅外动脉狭窄)患者在 1 年内缺血性脑卒中复发的风险最高(HR 2.04,95%CI 1.42-2.92,p=0.0001)。无论 hs-CRP 水平如何,无症状性颅内或颅外动脉狭窄与无动脉狭窄相比均不会增加缺血性事件的风险。
AIS 或 TIA 患者症状性颅内或颅外动脉狭窄与 1 年内缺血性脑卒中复发、脑卒中及 CVE 的风险增加相关,尤其是在 hs-CRP 水平升高的患者中。无论 hs-CRP 水平如何,无症状性颅内或颅外动脉狭窄与无动脉狭窄相比均不会增加缺血性事件的风险。